Gene · 489
Papers2,442
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,442
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent Developments on the Roles of Calcium Signals and Potential Therapy Targets in Cervical Cancer. | Cells | 2022 | 36230965 | PubTator, text mining | PubMed |
| Shrimp Lipid Prevents Endoplasmic Reticulum-Mediated Endothelial Cell Damage. | Foods | 2022 | 36230152 | PubTator, text mining | PubMed |
| Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies. | Front Physiol | 2022 | 36225299 | PubTator, text mining | PubMed |
| Ex vivo exposures to arsenite and its methylated trivalent metabolites alter gene transcription in mouse sperm cells. | Toxicol Appl Pharmacol | 2022 | 36209798 | PubTator, text mining | PubMed |
| Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy. | Front Cell Dev Biol | 2022 | 36200045 | PubTator, text mining | PubMed |
| Ontogeny of cardiomyocytes: ultrastructure optimization to meet the demand for tight communication in excitation-contraction coupling and energy transfer. | Philos Trans R Soc Lond B Biol Sci | 2022 | 36189816 | PubTator, text mining | PubMed |
| Avian cardiomyocyte architecture and what it reveals about the evolution of the vertebrate heart. | Philos Trans R Soc Lond B Biol Sci | 2022 | 36189815 | PubTator, text mining | PubMed |
| Aberrant calcium signalling downstream of mutations in TP53 and the PI3K/AKT pathway genes promotes disease progression and therapy resistance in triple negative breast cancer. | Cancer Drug Resist | 2022 | 36176752 | PubTator, text mining | PubMed |
| ER stress promotes mitochondrial DNA mediated type-1 interferon response in beta-cells and interleukin-8 driven neutrophil chemotaxis. | Front Endocrinol (Lausanne) | 2022 | 36171907 | PubTator, text mining | PubMed |
| The ryanodine receptor mutational characteristics and its indication for cancer prognosis. | Sci Rep | 2022 | 36167878 | PubTator, text mining | PubMed |
| Anti-malarial drugs: Mechanisms underlying their proarrhythmic effects. | Br J Pharmacol | 2022 | 36165125 | PubTator, text mining | PubMed |
| Shaped by leaky ER: Homeostatic Ca2+ fluxes. | Front Physiol | 2022 | 36160838 | PubTator, text mining | PubMed |
| Diabetic kidney disease in pediatric patients: A current review. | World J Diabetes | 2022 | 36159227 | PubTator, text mining | PubMed |
| ER-mitochondria contact sites; a multifaceted factory for Ca2+ signaling and lipid transport. | Front Cell Dev Biol | 2022 | 36158205 | PubTator, text mining | PubMed |
| Uremic toxins in chronic kidney disease highlight a fundamental gap in understanding their detrimental effects on cardiac electrophysiology and arrhythmogenesis. | Acta Physiol (Oxf) | 2022 | 36148604 | PubTator, text mining | PubMed |
| Integrins Increase Sarcoplasmic Reticulum Activity for Excitation-Contraction Coupling in Human Stem Cell-Derived Cardiomyocytes. | Int J Mol Sci | 2022 | 36142853 | PubTator, text mining | PubMed |
| Crosstalk between Ca2+ Signaling and Cancer Stemness: The Link to Cisplatin Resistance. | Int J Mol Sci | 2022 | 36142596 | PubTator, text mining | PubMed |
| Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines. | Cancers (Basel) | 2022 | 36139627 | PubTator, text mining | PubMed |
| Regulatory mechanisms and function of hypoxia-induced long noncoding RNA NDRG1-OT1 in breast cancer cells. | Cell Death Dis | 2022 | 36127332 | PubTator, text mining | PubMed |
| Therapeutic strategies in ischemic cardiomyopathy: Focus on mitochondrial quality surveillance. | EBioMedicine | 2022 | 36122552 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/489/papers?page=17